Contineum Therapeutics, Inc. Class A’s (CTNM) Moving Averages Convergence Divergence (MACD) indicator is -1.02, suggesting Contineum Therapeutics, Inc. Class A is a Buy.

Contineum Therapeutics, Inc. Class A’s (CTNM) 20-Day exponential moving average is 12.22, while Contineum Therapeutics, Inc. Class A’s (CTNM) share price is $10.35, making it a Sell.

Contineum Therapeutics, Inc. Class A’s (CTNM) 50-Day exponential moving average is 13.69, while Contineum Therapeutics, Inc. Class A’s (CTNM) share price is $10.35, making it a Sell.

Advanced Chart >

Contineum Therapeutics, Inc. Class A (CTNM) Pivot Points

Jan 31, 2025, 04:17 AM

Classic

10.01

10.24

10.35

10.58

10.69

10.92

11.03

Fibonacci

10.24

10.37

10.45

10.58

10.71

10.79

10.92

Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Contineum Therapeutics, Inc. Class A (CTNM) Moving Averages

Jan 31, 2025, 04:17 AM

MA5

10.81Sell

10.79Sell

MA10

11.44Sell

11.38Sell

MA20

12.66Sell

12.22Sell

MA50

13.77Sell

13.69Sell

MA100

15.71Sell

14.95Sell

MA200

16.69Sell

16.54Sell

Contineum Therapeutics, Inc. Class A’s (CTNM) 10-Day exponential moving average is 11.38, while Contineum Therapeutics, Inc. Class A’s (CTNM) share price is $10.35, making it a Sell.

Contineum Therapeutics, Inc. Class A’s (CTNM) 100-Day exponential moving average is 14.95, while Contineum Therapeutics, Inc. Class A’s (CTNM) share price is $10.35, making it a Sell.

Contineum Therapeutics, Inc. Class A’s (CTNM) stock price is $10.35 and Contineum Therapeutics, Inc. Class A’s (CTNM) 50-day simple moving average is 13.77, creating a Sell signal.

Contineum Therapeutics, Inc. Class A’s (CTNM) stock price is $10.35 and Contineum Therapeutics, Inc. Class A’s (CTNM) 100-day simple moving average is 15.71, creating a Sell signal.

Contineum Therapeutics, Inc. Class A’s (CTNM) stock price is $10.35 and Contineum Therapeutics, Inc. Class A’s (CTNM) 200-day simple moving average is 16.69, creating a Sell signal.

Contineum Therapeutics, Inc. Class A (CTNM) Technical Indicators

Jan 31, 2025, 04:17 AM

RSI (14)

19.46

Buy

STOCH (9,6)

1.75

Buy

STOCHRSI (14)

1.50

Buy

MACD (12,26)

-1.02

Buy

ADX (14)

33.58

Neutral

Williams %R

-96.18

Buy

CCI (14)

-126.78

Buy

ATR (14)

0.75

Ultimate Oscillator

20.05

Sell

ROC

-24.84

Sell

Contineum Therapeutics, Inc. Class A’s (CTNM) Relative Strength Index (RSI) is 19.46, creating a Buy signal.

Contineum Therapeutics, Inc. Class A’s (CTNM) Trend Strength Indicator (ADX) is 33.58, creating a Neutral signal.

Contineum Therapeutics, Inc. Class A’s (CTNM) Commodity Channel Index (CCI) is -126.78, creating a Buy signal.

Contineum Therapeutics, Inc. Class A’s (CTNM) Price Rate of Change (ROC) is -24.84, creating a Sell signal.

Technical Analysis Screener >

Technical Analysis Screener.

Customize your technical analysis to fit your
unique trading strategy with a flexible screener

Try it Now!

FAQ

Is CTNM a Buy, Hold, or Sell?

Based on CTNM’s technical indicators, CTNM is a Sell.

What is CTNM’s RSI (14)?

CTNM’s RSI (14) is 19.46, which suggests CTNM is a Buy.

What is CTNM’s MACD?

CTNM’s MACD is -1.02, which suggests CTNM is a Buy.

What is CTNM’s 5-day moving average?

CTNM’s 5-day moving average is 10.81, which suggests CTNM is a Sell.

What is CTNM’s 20-day moving average?

CTNM 20-day moving average is 12.66, which suggests CTNM is a Sell.

What is CTNM’s 50-day moving average?

CTNM’s 50-day moving average is 13.77, which suggests CTNM is a Sell.

What is CTNM’s 200-day moving average?

CTNM’s 200-day moving average is 16.69, which suggests CTNM is a Sell.

What is CTNM’s Williams % R (14)?

CTNM’s Williams % R (14) is -96.18, which suggests CTNM is a Buy.

What is CTNM’s CCI (14)?

CTNM’s CCI (14) is -126.78, which suggests CTNM is a Buy.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing